Genomic and biomarker data are complex and are not consistently converted into clear, patient-specific diagnostic or treatment decisions.
R&D Focus
High-throughput epigenomic profiling and epigenetic biomarkers
Innovative Solution
Genegoggle is a precision medicine biotech company with the goal of discovering novel therapeutics and intelligent systems to improve human health by leveraging multi-dimensional genomic and epigenetic elements.
Investment Funding
Last Funding Stage
Seed
Last Funding Date
15-09-2021
Startup Stage
Seed
Lead Investors
Illumina Accelerator
Revenue
Less than $1M
People
Founders
Jakub Mieczkowski
Marcin Kruczyk
Michal Marzecki
About
Genegoggle is a precision medicine biotech company with the goal of discovering novel therapeutics and intelligent systems to improve human health by leveraging multi-dimensional genomic and epigenetic elements.
Something missing or incorrect on this page? Help us enrich this information
